RHOPHYLAC (Rho(D) immune globulin)
RHO(D) IMMUNE GLOBULINS·IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
CSL Behring
Indication
Prevention of Rh isoimmunization after blood transfusion
Prevention of Rh isoimmunization after blood transfusion refers to an immunoprophylactic intervention aimed at stopping an immune response in Rh(D)-negative individuals who have received inadvertent or emergency transfusions of Rh(D)-positive red blood cells or Rh-incompatible blood components. Read more about Prevention of Rh isoimmunization after blood transfusion
15 drugs 10 manufacturers
Drugs that treat it
Common Prevention of Rh isoimmunization after blood transfusion therapies.
WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
APTEVO BIOTHERA
WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
BAXALTA US INC.
WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
SAOL THERAPEUTI
HYPERRHO S/D (Rho(D) immune globulin)
RHO(D) IMMUNE GLOBULINS·PREVENTION OF RH ISOIMMUNIZATION AT FIRST-TRIMESTER PREGNANCY TERMINATION·+2
TALECRIS BIOTHE
WINRHO SDF (Rho(D) immune globulin/maltose)
RHO(D) IMMUNE GLOBULINS·IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
KAMADA LTD.
Filter & compare in the drug finder →Opens the drug finder with Prevention of Rh isoimmunization after blood transfusion preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of Rh isoimmunization after blood transfusion refers to an immunoprophylactic intervention aimed at stopping an immune response in Rh(D)-negative individuals who have received inadvertent or emergency transfusions of Rh(D)-positive red blood cells or Rh-incompatible blood components.
In this hematologic and immunological state, exposure to the highly immunogenic foreign Rh(D) surface antigen prompts the recipient's immune system to generate anti-D alloantibodies.
Although typically asymptomatic in the recipient at the time of exposure, this humoral sensitization leads to permanent alloimmunization, creating a substantial risk of acute or delayed hemolytic transfusion reactions with future blood exposures and severe hemolytic disease of the fetus and newborn in future pregnancies.
Prevention focuses primarily on individuals with childbearing potential and transfusion-dependent patients to clear circulating foreign Rh(D)-positive erythrocytes before primary antibody induction occurs.
- nih.gov
Prevention of Rh isoimmunization after blood transfusion refers to an immunoprophylactic intervention aimed at stopping an immune response in Rh(D)-negative individuals who have received inadvertent or emergency transfusions of Rh(D)-positive red blood cells or Rh-incompatible blood components Prevention focuses primarily on individuals with childbearing potential and transfusion-dependent patients to clear circulating foreign Rh(D)-positive erythrocytes before primary antibody induction occurs
- nih.gov
Prevention of Rh isoimmunization after blood transfusion refers to an immunoprophylactic intervention aimed at stopping an immune response in Rh(D)-negative individuals who have received inadvertent or emergency transfusions of Rh(D)-positive red blood cells or Rh-incompatible blood components
- nih.gov
In this hematologic and immunological state, exposure to the highly immunogenic foreign Rh(D) surface antigen prompts the recipient's immune system to generate anti-D alloantibodies Although typically asymptomatic in the recipient at the time of exposure, this humoral sensitization leads to permanent alloimmunization, creating a substantial risk of acute or delayed hemolytic transfusion reactions with future blood exposures and severe hemolytic disease of the fetus and newborn in future pregnanc...
- nih.gov
In this hematologic and immunological state, exposure to the highly immunogenic foreign Rh(D) surface antigen prompts the recipient's immune system to generate anti-D alloantibodies Although typically asymptomatic in the recipient at the time of exposure, this humoral sensitization leads to permanent alloimmunization, creating a substantial risk of acute or delayed hemolytic transfusion reactions with future blood exposures and severe hemolytic disease of the fetus and newborn in future pregnanc...
- nih.gov
Prevention focuses primarily on individuals with childbearing potential and transfusion-dependent patients to clear circulating foreign Rh(D)-positive erythrocytes before primary antibody induction occurs
Personalize your experience
Follow Prevention of Rh isoimmunization after blood transfusion and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.